For patients who have not achieved adequate glycemic control with existing medications or lifestyle modifications alone, GLP-1 therapy offers a potent alternative with greater potency and longer half-life compared to some other GLP-1 RA therapies
Darshan Shah, MD, board-certified surgeon, published author, and co-founder of NEXT|HEALTH, the fastest-growing health optimization and longevity clinic network
Wegovy, a drug that is approved for weight loss, is covered by just 1% of Marketplace prescription drug plans, compared to 82% of Marketplace prescription drug plans for Ozempic, which contains the same active ingredient as Wegovy (semaglutide) but is approved only for diabetes
The right response to prevent lean mass loss is nutrition and resistance training support, not assuming that a lower drug dose is inherently muscle-sparing